P454: VENETOCLAX AND GILTERITINIB SYNERGIZE IN FLT3 WILDTYPE ACUTE MYELOID LEUKEMIA BY SUPPRESSION OF MCL-1 VIA COMBINED AXL AND FLT3 TARGETING. (23rd June 2022) - Schmidt, C.; Janssen, M.; Bruch, P.-M.; Blank, M. F.; Rohde, C.; Waclawiczek, A.; Renders, S.; Heid, D.; Göllner, S.; Vierbaum, L.; Weidenauer, K.; Herbst, S.; et al.